Swiss biotechnology company Evolva, which is backed by a venture capital consortium including Novartis Venture, Aravis, Sunstone Capital and Dansk Innovationsinvestering, has acquired listed rival Arpida. The combined entity is to seek a listing on the Swiss stock exchange.
Second vehicle will be larger than its predecessor, which closed on €843m in March 2010
Dieter von Holtzbrinck Ventures (DvH Ventures) has announced the launch of its first Digital Health fund, which has held a first close on €60m.
Sale ends a three-year holding period for Astorg, which acquired a 75% stake in the company from Xenon PE
Acquisition of Germany-based x-ray equipment and software was backed by senior debt from ApoBank